Inventor
LIU JIWEN
US29 patents
⚠️ This page may combine multiple inventors who share the name “LIU JIWEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
16 patentsUS7541383B2Jun 2, 2009
Asthma and allergic inflammation modulators
AMGEN INC86 citations95
US6964967B2Nov 15, 2005
Substituted pyrido[2,3-d]pyrimidines and methods for their use
AMGEN INC35 citations92
US6884782B2Apr 26, 2005
STAT modulators
AMGEN INC23 citations92
US7321001B2Jan 22, 2008
Asthma and allergic inflammation modulators
AMGEN INC39 citations90
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US8030354B2Oct 4, 2011
Substituted biphenyl GPR40 modulators
AMGEN INC11 citations83
US7939538B2May 10, 2011
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
AMGEN INC20 citations83
US7816367B2Oct 19, 2010
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
AMGEN INC15 citations83
US7649110B2Jan 19, 2010
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
AMGEN INC8 citations83
US7582803B2Sep 1, 2009
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
AMGEN INC17 citations83
US7465804B2Dec 16, 2008
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
AMGEN INC3 citations63
US7687526B2Mar 30, 2010
Benzo-fused compounds for use in treating metabolic disorders
AMGEN INC5 citations62
US8003648B2Aug 23, 2011
Heterocyclic GPR40 modulators
AMGEN INC1 citations50
US7714008B2May 11, 2010
Heterocyclic GPR40 modulators
AMGEN INC0 citations50
US7960567B2Jun 14, 2011
Compounds and methods useful for treating asthma and allergic inflammation
AMGEN INC0 citations41
AMGEN SF LLC
3 patentsUS7053215B2May 30, 2006
Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their use
AMGEN SF LLC47 citations94
US7375102B2May 20, 2008
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
AMGEN SF LLC27 citations91
US7067662B2Jun 27, 2006
CXCR3 antagonists
AMGEN SF LLC31 citations91
TEON THERAPEUTICS INC
3 patentsUS11957689B2Apr 16, 2024
Cannabinoid receptor type 2 (CB2) modulators and uses thereof
TEON THERAPEUTICS INC0 citations60
US11564928B1Jan 31, 2023
Cannabinoid receptor type 2 (CB2) modulators and uses thereof
TEON THERAPEUTICS INC1 citations60
US11124515B2Sep 21, 2021
Adenosine receptor antagonists and uses thereof
TEON THERAPEUTICS INC0 citations49